410 related articles for article (PubMed ID: 24610009)
1. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.
Wilson NS; Duewell P; Yang B; Li Y; Marsters S; Koernig S; Latz E; Maraskovsky E; Morelli AB; Schnurr M; Ashkenazi A
J Immunol; 2014 Apr; 192(7):3259-68. PubMed ID: 24610009
[TBL] [Abstract][Full Text] [Related]
2. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.
Marty-Roix R; Vladimer GI; Pouliot K; Weng D; Buglione-Corbett R; West K; MacMicking JD; Chee JD; Wang S; Lu S; Lien E
J Biol Chem; 2016 Jan; 291(3):1123-36. PubMed ID: 26555265
[TBL] [Abstract][Full Text] [Related]
3. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
4. ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.
Wilson NS; Yang B; Morelli AB; Koernig S; Yang A; Loeser S; Airey D; Provan L; Hass P; Braley H; Couto S; Drane D; Boyle J; Belz GT; Ashkenazi A; Maraskovsky E
Immunol Cell Biol; 2012 May; 90(5):540-52. PubMed ID: 21894173
[TBL] [Abstract][Full Text] [Related]
5. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
6. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
7. ISCOMs and ISCOMATRIX.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
9. Malassezia yeasts activate the NLRP3 inflammasome in antigen-presenting cells via Syk-kinase signalling.
Kistowska M; Fenini G; Jankovic D; Feldmeyer L; Kerl K; Bosshard P; Contassot E; French LE
Exp Dermatol; 2014 Dec; 23(12):884-9. PubMed ID: 25267545
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
[TBL] [Abstract][Full Text] [Related]
11. ASC controls IFN-γ levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida.
Pierini R; Perret M; Djebali S; Juruj C; Michallet MC; Förster I; Marvel J; Walzer T; Henry T
J Immunol; 2013 Oct; 191(7):3847-57. PubMed ID: 23975862
[TBL] [Abstract][Full Text] [Related]
12. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Innate and Adaptive Immune Responses in PYNOD-Deficient Mice.
Nakajima S; Imamura R; Yoshino M; Sakurai M; Tsuchiya K; Sugihara K; Asano M; Suda T
Immunohorizons; 2018 Apr; 2(4):129-141. PubMed ID: 31022691
[TBL] [Abstract][Full Text] [Related]
14. The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis.
van de Veerdonk FL; Joosten LA; Shaw PJ; Smeekens SP; Malireddi RK; van der Meer JW; Kullberg BJ; Netea MG; Kanneganti TD
Eur J Immunol; 2011 Aug; 41(8):2260-8. PubMed ID: 21681738
[TBL] [Abstract][Full Text] [Related]
15. Inflammasome activation and inhibition in primary murine bone marrow-derived cells, and assays for IL-1α, IL-1β, and caspase-1.
Schneider KS; Thomas CJ; Groß O
Methods Mol Biol; 2013; 1040():117-35. PubMed ID: 23852601
[TBL] [Abstract][Full Text] [Related]
16. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18.
Conforti-Andreoni C; Spreafico R; Qian HL; Riteau N; Ryffel B; Ricciardi-Castagnoli P; Mortellaro A
J Immunol; 2011 Dec; 187(11):5842-50. PubMed ID: 22058415
[TBL] [Abstract][Full Text] [Related]
17. Caspase-1: the inflammasome and beyond.
Sollberger G; Strittmatter GE; Garstkiewicz M; Sand J; Beer HD
Innate Immun; 2014 Feb; 20(2):115-25. PubMed ID: 23676582
[TBL] [Abstract][Full Text] [Related]
18. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M
Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520
[TBL] [Abstract][Full Text] [Related]
19. IL-1α and inflammasome-independent IL-1β promote neutrophil infiltration following alum vaccination.
Oleszycka E; Moran HB; Tynan GA; Hearnden CH; Coutts G; Campbell M; Allan SM; Scott CJ; Lavelle EC
FEBS J; 2016 Jan; 283(1):9-24. PubMed ID: 26536497
[TBL] [Abstract][Full Text] [Related]
20. Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.
den Brok MH; Büll C; Wassink M; de Graaf AM; Wagenaars JA; Minderman M; Thakur M; Amigorena S; Rijke EO; Schrier CC; Adema GJ
Nat Commun; 2016 Nov; 7():13324. PubMed ID: 27819292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
